McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma

doi:10.3748/wjg.v20.i34.12226

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 34

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6219)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

309

WORD

164

HTML

2812

Figures (1-1)

222

Tables (1-4)

183

Sum=3690

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1193

Download

1336

Sum=2529

Sep 14, 2014 (publication date) through Dec 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 14, 2014; 20(34): 12226-12232
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12226

Table 3 Survival probabilities¹ by McGill Brisbane Symptom Score and chemotherapy

Time (mo)	Probability if high MBSS (95%CI)	Probability if low MBSS (95%CI)
Chemotherapy
12	0.69 (0.48-0.83)	0.80 (0.58-0.91)
24	0.33 (0.16-0.52)	0.64 (0.42-0.79)
No chemotherapy
12	0.41 (0.19-0.63)	0.90 (0.47-0.99)
24	0.35 (0.14-0.57)	0.60 (0.25-0.83)

¹Survivor function is calculated over full data and evaluated at indicated times. MBSS: McGill Brisbane Symptom Score.

Citation: Jamal MH, Doi SAR, Moser AJ, Dumitra S, Khalil JA, Simoneau E, Chaudhury P, Onitilo AA, Metrakos P, Barkun JS. McGill Brisbane Symptom Score for patients with resectable pancreatic head adenocarcinoma. World J Gastroenterol 2014; 20(34): 12226-12232
URL: https://www.wjgnet.com/1007-9327/full/v20/i34/12226.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i34.12226